AffyImmune Therapeutics

AffyImmune Therapeutics Appoints Matt Britz as Chief Executive Officer and Pete Gelinas as SVP of CMC

March 19, 2024 08:00 AM Eastern Daylight Time NATICK, Mass.–(BUSINESS WIRE)–AffyImmune Therapeutics, Inc., a clinical-stage biopharmaceutical company committed to developing novel, first-in-class, affinity-tuned CAR T cell therapies, announced today the appointment of Matt Britz to Chief Executive Officer and Pete Gelinas as Senior Vice President of Chemistry, Manufacturing, and Controls. “Matt has been an instrumental part of AffyImmune’s growth in the past two years”Post this … Continue reading AffyImmune Therapeutics Appoints Matt Britz as Chief Executive Officer and Pete Gelinas as SVP of CMC

Cellino

Cellino Announces Ed Tekeian as Senior Vice President of Engineering

–Tekeian will oversee the development of Cellino’s scalable manufacturing platform for personalized regenerative medicines. March 18, 2024 09:00 AM Eastern Daylight Time CAMBRIDGE, Mass.–(BUSINESS WIRE)–Cellino Biotech, Inc., a preclinical biotechnology company building an autonomous biomanufacturing platform for personalized regenerative medicine, today announced the expansion of its executive leadership team with the addition of Ed Tekeian as Senior Vice President of Engineering. As an experienced engineering … Continue reading Cellino Announces Ed Tekeian as Senior Vice President of Engineering

GRO Biosciences

GRO Biosciences Expands Executive Team with Appointment of Biopharma Veteran Tracey Lodie, PhD as Chief Development Officer

March 18, 2024 06:55 AM Eastern Daylight Time BOSTON–(BUSINESS WIRE)–GRO Biosciences Inc. (“GRObio”), an emerging biotechnology company leveraging synthetic biology to expand the amino acid alphabet and deliver on the promise of protein therapeutics, today announced the expansion of its leadership with the hire of Tracey Lodie, PhD as Chief Development Officer. “We are delighted to add Tracey to our executive team. Her world-class experience in immunology, clinical … Continue reading GRO Biosciences Expands Executive Team with Appointment of Biopharma Veteran Tracey Lodie, PhD as Chief Development Officer

Lucas Vitale

Lucas Vitale Joins Orthofix as Chief People and Business Operations Officer

March 18, 2024 07:00 AM Eastern Daylight Time LEWISVILLE, Texas–(BUSINESS WIRE)–Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced that Lucas Vitale has joined the company in the newly created role of Chief People and Business Operations Officer. “I look forward to being a part of the team that will help further advance the company as we focus on continuous improvements … Continue reading Lucas Vitale Joins Orthofix as Chief People and Business Operations Officer

AllerVie Health

AllerVie Health Names Rachel Russell as New Chief Experience Officer

AllerVie advances Russell to CXO, prioritizing patient satisfaction with technology-driven practice integration March 13, 2024 09:00 AM Eastern Daylight Time DALLAS–(BUSINESS WIRE)–Today, AllerVie Health, a national network of allergy clinics, announced that Rachel Russell will be the company’s new chief experience officer (CXO). The advancement from chief marketing, integration, and technology officer to CXO reflects AllerVie’s ongoing dedication to enhancing the patient experience and continuing its … Continue reading AllerVie Health Names Rachel Russell as New Chief Experience Officer